Healthcare Industry News: PET/CT
News Release - March 11, 2011
Lantheus Medical Imaging Receives Special Protocol Assessment Approval from FDA for Phase 3 Trial of Flurpiridaz F-18 for the Diagnosis of Coronary Artery Disease
Source: Lantheus Medical Imaging
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
